Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE)

NCT ID: NCT02662322

Last Updated: 2018-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

294 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-10

Study Completion Date

2017-09-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare three communications during peripheral intravenous catheterization and measure pain patient: one hypnotic, confusion (HYPNOSIS), an other with negative connotation (NOCEBO) and at least with neutral connotation (NEUTRAL).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinicians used to warn patients of pain or discomfort before potentially painful procedures like peripherical intravenous catheterization (PIVC). However, suggestions for negative perceptual experiences causes more pain and anxiety. During This does not improve at all the real-life experience of the act. On the contrary, the use of gentler words improves pain perception and subjective patient experience. Furthermore, hypnosis has been demonstrated as efficient and the pain perception seems to be modulate by hypnotic suggestions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HYPNOSIS

hypnotic communication, confusion procedure during peripheral intravenous catheterization

Group Type EXPERIMENTAL

Hypnotic communication

Intervention Type OTHER

hypnotic communication during peripheral intravenous catheterization

peripheral intravenous catheterization

Intervention Type OTHER

peripheral intravenous catheterization

NOCEBO

negative connotation communication during peripheral intravenous catheterization

Group Type ACTIVE_COMPARATOR

negative connotation communication

Intervention Type OTHER

negative connotation communication during peripheral intravenous catheterization

peripheral intravenous catheterization

Intervention Type OTHER

peripheral intravenous catheterization

NEUTRAL

neutral connotation communication during peripheral intravenous catheterization

Group Type PLACEBO_COMPARATOR

neutral connotation communication

Intervention Type OTHER

neutral connotation communication during peripheral intravenous catheterization

peripheral intravenous catheterization

Intervention Type OTHER

peripheral intravenous catheterization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypnotic communication

hypnotic communication during peripheral intravenous catheterization

Intervention Type OTHER

negative connotation communication

negative connotation communication during peripheral intravenous catheterization

Intervention Type OTHER

neutral connotation communication

neutral connotation communication during peripheral intravenous catheterization

Intervention Type OTHER

peripheral intravenous catheterization

peripheral intravenous catheterization

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 18 years
* peripheral intravenous catheterization of 20 G on the dorsal face of the hand before a planned surgery
* written and informed patient consent


* patient unable to communicate in french
* difficult vein access characteristics
* premedication
* pregnant, breast-feeding woman
* patient subject of legal protection

Exclusion Criteria

* failed of the first attempt of peripheral intravenous catheterization
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Helene Beloeil, PH

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status

CHU

Rennes, , France

Site Status

Centre Hospitalier Privé Saint Grégoire

Saint-Grégoire, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France

References

Explore related publications, articles, or registry entries linked to this study.

Fusco N, Bernard F, Roelants F, Watremez C, Musellec H, Laviolle B, Beloeil H; Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE) group. Hypnosis and communication reduce pain and anxiety in peripheral intravenous cannulation: Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE), a multicentre randomised trial. Br J Anaesth. 2020 Mar;124(3):292-298. doi: 10.1016/j.bja.2019.11.020. Epub 2019 Dec 18.

Reference Type DERIVED
PMID: 31862159 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC15_9868

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.